AI assistant
BIOGEN INC. — Director's Dealing 2015
Feb 10, 2015
30291_dirs_2015-02-10_1b237bb8-ec3e-4e7b-b7a7-9a8b2831c595.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2015-02-08
Reporting Person: Holtzman Steven H (EVP Corporate Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-08 | Common Stock | M | 2705 | — | Acquired | 5802 | Direct |
| 2015-02-08 | Common Stock | F | 1275 | $402.00 | Disposed | 4527 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-08 | Restricted Stock Unit | $0 | M | 2705 | Disposed | 2016-02-08 | Common Stock (2705) | Direct |
Footnotes
F1: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).